QNRXQuoin Pharmaceuticals, Ltd. American Depositary Shares
Identity
- Security key
- 20651
- Ticker
- QNRX
- Type
- ADRC — American Depository Receipt Common
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2021-10-28
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- QNRX
Detail
Enriched 2026-08-14 20:47
- Market cap
- $11,829,582.02
- Shares outstanding (class)
- 2,008,418
- Shares outstanding (weighted)
- 2,008,418
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 6
- Location
- KFAR SABA
- Homepage
- https://www.quoinpharma.com
- Description
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.